Lopinavir-Ritonavir Does Not Offer Substantial Benefit in Severe COVID-19
In patients who were hospitalized with severe coronavirus disease, treatment with lopinavir-ritonavir did not provide a substantial benefit beyond standard care.
All articles by Britt Gambino
American Thoracic Society Releases Statement in Response to COVID-19
The leadership of American Thoracic Society recently released a statement, as well as 2 fact sheets, in response to the COVID-19 outbreak.
COVID-19 Preparation Recommendations From the COPD Foundation
The COPD Foundation released practical recommendations for patients living with COPD who may have concerns about COVID-19.
Asthma, COPD, and Asthma-COPD Overlap Differentiated Using Sputum Cell Count
Sputum cell count, as measured by a simplified method, was able to differentiate between asthma, COPD, and asthma-COPD overlap.
Current Lung Cancer Screening Guidelines Suboptimal in Identifying At-Risk Women
Current US Preventive Services Task Force guidelines are not applicable to most women at risk for lung cancer.
Acute Lipoid Pneumonia in Adults Who Used Marijuana Oils in E-Cigarettes
After recent use of marijuana oils in e-cigarettes, 5 patients in North Carolina were diagnosed with acute exogenous lipoid pneumonia.
ABIM, ACC Announce New Pathway for Maintenance of Board Certification in Cardiology
The American Board of Internal Medicine and the American College of Cardiology have created the Collaborative Maintenance Pathway option for cardiologists to maintain their board certification.
Novel Peptide-Based Immunotherapy Holds Promise for Peanut Allergy
This article is part of Pulmonology Advisor‘s coverage of the American Academy of Allergy, Asthma & Immunology annual meeting, taking place in San Francisco, California. Our staff will report on medical research related to asthma, allergy, and other respiratory conditions, conducted by experts in the field. Check back regularly for more news from AAAAI 2019.…
Childhood Behavioral Interventions May Promote Adult Cardiovascular Health
Focusing on children for health promotion, strategies for program implementation, and gaps in research may be a successful approach for lifelong cardiovascular health.
CHEST Releases Guideline for Antithrombotic Therapy in Atrial Fibrillation
Patients with atrial fibrillation who have ≥1 non-sex CHA2DS2VASc stroke risk factor should receive oral anticoagulation as antithrombotic therapy.
Next post in Cardiovascular Disease Information Center
